nodes	percent_of_prediction	percent_of_DWPC	metapath
Frovatriptan—Renal pain—Octreotide—thymus cancer	0.0444	0.0444	CcSEcCtD
Frovatriptan—Peptic ulcer—Octreotide—thymus cancer	0.0349	0.0349	CcSEcCtD
Frovatriptan—Coagulopathy—Octreotide—thymus cancer	0.03	0.03	CcSEcCtD
Frovatriptan—Tingling sensation—Octreotide—thymus cancer	0.0291	0.0291	CcSEcCtD
Frovatriptan—Numbness—Octreotide—thymus cancer	0.0282	0.0282	CcSEcCtD
Frovatriptan—Sensory loss—Octreotide—thymus cancer	0.027	0.027	CcSEcCtD
Frovatriptan—Arthropathy—Octreotide—thymus cancer	0.0257	0.0257	CcSEcCtD
Frovatriptan—Eructation—Octreotide—thymus cancer	0.023	0.023	CcSEcCtD
Frovatriptan—Cramps of lower extremities—Octreotide—thymus cancer	0.0215	0.0215	CcSEcCtD
Frovatriptan—Urine output increased—Octreotide—thymus cancer	0.0211	0.0211	CcSEcCtD
Frovatriptan—Polyuria—Octreotide—thymus cancer	0.0193	0.0193	CcSEcCtD
Frovatriptan—Hot flush—Octreotide—thymus cancer	0.0181	0.0181	CcSEcCtD
Frovatriptan—Amnesia—Octreotide—thymus cancer	0.0181	0.0181	CcSEcCtD
Frovatriptan—Menopausal symptoms—Octreotide—thymus cancer	0.018	0.018	CcSEcCtD
Frovatriptan—Hypoglycaemia—Octreotide—thymus cancer	0.0174	0.0174	CcSEcCtD
Frovatriptan—Pain in extremity—Octreotide—thymus cancer	0.017	0.017	CcSEcCtD
Frovatriptan—Osteoarthritis—Octreotide—thymus cancer	0.017	0.017	CcSEcCtD
Frovatriptan—Dehydration—Octreotide—thymus cancer	0.0158	0.0158	CcSEcCtD
Frovatriptan—Muscular weakness—Octreotide—thymus cancer	0.015	0.015	CcSEcCtD
Frovatriptan—Sweating increased—Octreotide—thymus cancer	0.0143	0.0143	CcSEcCtD
Frovatriptan—Pollakiuria—Octreotide—thymus cancer	0.0135	0.0135	CcSEcCtD
Frovatriptan—Depression—Octreotide—thymus cancer	0.013	0.013	CcSEcCtD
Frovatriptan—Conjunctivitis—Octreotide—thymus cancer	0.0127	0.0127	CcSEcCtD
Frovatriptan—Epistaxis—Octreotide—thymus cancer	0.0123	0.0123	CcSEcCtD
Frovatriptan—Sinusitis—Octreotide—thymus cancer	0.0123	0.0123	CcSEcCtD
Frovatriptan—Bradycardia—Octreotide—thymus cancer	0.0119	0.0119	CcSEcCtD
Frovatriptan—Rhinitis—Octreotide—thymus cancer	0.0118	0.0118	CcSEcCtD
Frovatriptan—Hypoaesthesia—Octreotide—thymus cancer	0.0117	0.0117	CcSEcCtD
Frovatriptan—Pharyngitis—Octreotide—thymus cancer	0.0116	0.0116	CcSEcCtD
Frovatriptan—Visual impairment—Octreotide—thymus cancer	0.0113	0.0113	CcSEcCtD
Frovatriptan—Tinnitus—Octreotide—thymus cancer	0.0109	0.0109	CcSEcCtD
Frovatriptan—Flushing—Octreotide—thymus cancer	0.0109	0.0109	CcSEcCtD
Frovatriptan—Arrhythmia—Octreotide—thymus cancer	0.0105	0.0105	CcSEcCtD
Frovatriptan—Mental disorder—Octreotide—thymus cancer	0.0103	0.0103	CcSEcCtD
Frovatriptan—Malnutrition—Octreotide—thymus cancer	0.0102	0.0102	CcSEcCtD
Frovatriptan—Flatulence—Octreotide—thymus cancer	0.0101	0.0101	CcSEcCtD
Frovatriptan—Tension—Octreotide—thymus cancer	0.01	0.01	CcSEcCtD
Frovatriptan—Nervousness—Octreotide—thymus cancer	0.00992	0.00992	CcSEcCtD
Frovatriptan—Back pain—Octreotide—thymus cancer	0.00988	0.00988	CcSEcCtD
Frovatriptan—Muscle spasms—Octreotide—thymus cancer	0.00982	0.00982	CcSEcCtD
Frovatriptan—Tremor—Octreotide—thymus cancer	0.00957	0.00957	CcSEcCtD
Frovatriptan—Ill-defined disorder—Octreotide—thymus cancer	0.00948	0.00948	CcSEcCtD
Frovatriptan—Agitation—Octreotide—thymus cancer	0.00939	0.00939	CcSEcCtD
Frovatriptan—Malaise—Octreotide—thymus cancer	0.00921	0.00921	CcSEcCtD
Frovatriptan—Vertigo—Octreotide—thymus cancer	0.00918	0.00918	CcSEcCtD
Frovatriptan—Syncope—Octreotide—thymus cancer	0.00916	0.00916	CcSEcCtD
Frovatriptan—Palpitations—Octreotide—thymus cancer	0.00903	0.00903	CcSEcCtD
Frovatriptan—Loss of consciousness—Octreotide—thymus cancer	0.00898	0.00898	CcSEcCtD
Frovatriptan—Convulsion—Octreotide—thymus cancer	0.00885	0.00885	CcSEcCtD
Frovatriptan—Chest pain—Octreotide—thymus cancer	0.00869	0.00869	CcSEcCtD
Frovatriptan—Myalgia—Octreotide—thymus cancer	0.00869	0.00869	CcSEcCtD
Frovatriptan—Arthralgia—Octreotide—thymus cancer	0.00869	0.00869	CcSEcCtD
Frovatriptan—Anxiety—Octreotide—thymus cancer	0.00866	0.00866	CcSEcCtD
Frovatriptan—Discomfort—Octreotide—thymus cancer	0.00859	0.00859	CcSEcCtD
Frovatriptan—Dry mouth—Octreotide—thymus cancer	0.0085	0.0085	CcSEcCtD
Frovatriptan—Anaphylactic shock—Octreotide—thymus cancer	0.00834	0.00834	CcSEcCtD
Frovatriptan—Shock—Octreotide—thymus cancer	0.0082	0.0082	CcSEcCtD
Frovatriptan—Tachycardia—Octreotide—thymus cancer	0.00813	0.00813	CcSEcCtD
Frovatriptan—Hyperhidrosis—Octreotide—thymus cancer	0.00806	0.00806	CcSEcCtD
Frovatriptan—Anorexia—Octreotide—thymus cancer	0.00795	0.00795	CcSEcCtD
Frovatriptan—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00759	0.00759	CcSEcCtD
Frovatriptan—Insomnia—Octreotide—thymus cancer	0.00754	0.00754	CcSEcCtD
Frovatriptan—Paraesthesia—Octreotide—thymus cancer	0.00748	0.00748	CcSEcCtD
Frovatriptan—Dyspnoea—Octreotide—thymus cancer	0.00743	0.00743	CcSEcCtD
Frovatriptan—Somnolence—Octreotide—thymus cancer	0.00741	0.00741	CcSEcCtD
Frovatriptan—Dyspepsia—Octreotide—thymus cancer	0.00734	0.00734	CcSEcCtD
Frovatriptan—Decreased appetite—Octreotide—thymus cancer	0.00725	0.00725	CcSEcCtD
Frovatriptan—Fatigue—Octreotide—thymus cancer	0.00719	0.00719	CcSEcCtD
Frovatriptan—Pain—Octreotide—thymus cancer	0.00713	0.00713	CcSEcCtD
Frovatriptan—Constipation—Octreotide—thymus cancer	0.00713	0.00713	CcSEcCtD
Frovatriptan—Feeling abnormal—Octreotide—thymus cancer	0.00687	0.00687	CcSEcCtD
Frovatriptan—Gastrointestinal pain—Octreotide—thymus cancer	0.00682	0.00682	CcSEcCtD
Frovatriptan—Abdominal pain—Octreotide—thymus cancer	0.00659	0.00659	CcSEcCtD
Frovatriptan—Body temperature increased—Octreotide—thymus cancer	0.00659	0.00659	CcSEcCtD
Frovatriptan—Hypersensitivity—Octreotide—thymus cancer	0.00614	0.00614	CcSEcCtD
Frovatriptan—Asthenia—Octreotide—thymus cancer	0.00598	0.00598	CcSEcCtD
Frovatriptan—Pruritus—Octreotide—thymus cancer	0.0059	0.0059	CcSEcCtD
Frovatriptan—Diarrhoea—Octreotide—thymus cancer	0.0057	0.0057	CcSEcCtD
Frovatriptan—Dizziness—Octreotide—thymus cancer	0.00551	0.00551	CcSEcCtD
Frovatriptan—Vomiting—Octreotide—thymus cancer	0.0053	0.0053	CcSEcCtD
Frovatriptan—Headache—Octreotide—thymus cancer	0.00522	0.00522	CcSEcCtD
Frovatriptan—Nausea—Octreotide—thymus cancer	0.00495	0.00495	CcSEcCtD
